VEGF Pathway and Retinal Angiogenesis Pathological ocular angiogenesis the basis of proliferative diabetic retinopathy (PDR), wet age-related macular degeneration (AMD), and retinopathy of prematurity (ROP) is predominantly driven by VEGF-A overexpression in response to tissue hypoxia, oxidative stress, and advanced glycation end-product (AGE) accumulation
info please What a great experience
After one month of weekly lipotropic injections (45 shots), patients commonly report: measurably improved energy levels (often week 1), reduced afternoon fatigue, improved exercise recovery, and combined with appropriate caloric management and exercise more consistent weight management outcomes
The FDA has not evaluated the safety or effectiveness of compounded BPC-157 for these indications
Patients can obtain it through legitimate medical channels with physician oversight, quality assurance, and ongoing monitoring